Open AccessVildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes
Author(s) -
Plamen Kozlovski,
James E. Foley,
Qing Shao,
Valentina Lukashevich,
Wolfgang Kothny
Publication year - 2013
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v4.i4.151
Subject(s) - vildagliptin , medicine , metformin , tolerability , hypoglycemia , placebo , glycemic , type 2 diabetes , diabetes mellitus , insulin , clinical endpoint , type 2 diabetes mellitus , endocrinology , gastroenterology , post hoc analysis , dipeptidyl peptidase 4 inhibitor , pioglitazone , randomized controlled trial , adverse effect , alternative medicine , pathology
To assess the efficacy and safety of vildagliptin 50 mg bid as add-on therapy to insulin in Asian patients with type 2 diabetes mellitus (T2DM).